Two Sigma Securities’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Two Sigma Securities’s Portfolio GMVD Stock Details GMVD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,407	Closed	-$11K	–	3444
2022 Q3	$11K	Buy	1,407 +925	+192%	+$13.6K	﹤0.01%	2392
2022 Q2	$10K	Buy	+482	New	+$15.2K	﹤0.01%	2058

Other funds holding GMVD

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Two Sigma Securities's GMVD Position: Q4 2022 in Review

Two Sigma Securities sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q4 2022, closing a stake of 1,407 shares — an estimated $11K sold.

Two Sigma Securities first reported a position in GMVD in Q2 2022 and held it in 2 quarters. The position peaked at $11K in Q3 2022. 6 funds tracked by Wall St. Rank hold GMVD as of Q4 2022.

Two Sigma Securities reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Two Sigma Securities sold 1,407 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q4 2022, an estimated $11K.
Two Sigma Securities first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q2 2022 and held it in 2 quarters.
Two Sigma Securities's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $11K in Q3 2022.
6 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.